Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00685113 · ClinicalTrials.gov registry record · Phase 3
A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder
A Phase 3 study, sponsored by Duramed Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,104
- Enrollment target
NCT00685113: Completed Phase 3 study, sponsored by Duramed Research.
NCT00685113 is a Phase 3 study that has completed, run by Duramed Research. The registered enrollment target is 1,104 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (43% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00685113, a Phase 3 study, has completed, sponsored by Duramed Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,104 participants
- Enrollment target
Study Summary
This is a multicenter study to evaluate the efficacy and safety of 2 different doses of DR-3001. For eligible subjects the duration of the study will be approximately 20 weeks; this will consist of a 4-week screening period, a 12-week treatment period and a 4-week follow-up period. Subjects will have physical and laboratory exams, including blood draws at each scheduled visit. Subjects will be required to insert a vaginal ring (replacing it every 4 weeks) and to keep a daily record of their toilet voids (including time,type and volume) for 3 days at several specified time points.
Interventions
- DRUG Placebo
- DRUG DR-3001
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,104 participants |
| Start Date | 2008-05 |
| Est. Completion | 2010-03 |
| Phase | Phase 3 |
What the finished NCT00685113 record still lists
NCT00685113 is an interventional study that assigns participants to a tested intervention. Its 1,104 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (43% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00685113 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00685113 about?
NCT00685113 is a clinical study titled "A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder". This is a multicenter study to evaluate the efficacy and safety of 2 different doses of DR-3001. For eligible subjects the duration of the study will be approximately 20 weeks; this will consist of a 4-week screening period, a 12-week treatment period and a 4-week follow-up period. Subjects will hav...
What is the current status of trial NCT00685113?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,104 participants. The study started on 2008-05. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00685113?
The interventions under investigation include: Placebo (DRUG), DR-3001 (DRUG).
Who is sponsoring clinical trial NCT00685113?
This trial is sponsored by Duramed Research, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00685113's enrollment target sits among peer trials
1,104 252nd of 2000 higher than 1,749 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00710112 · 1,100 participants
Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
- NCT02688517 · 1,100 participants
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
- NCT04743765 · 1,100 participants · NA
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
- NCT05638581 · 1,100 participants · Phase 3
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia